Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 13:55 ET | Source: Persona AI

Persona AI Mengumumkan Brian Davis sebagai Kepala Manufaktur Global

HOUSTON, April 01, 2026 (GLOBE NEWSWIRE) -- Persona AI, pemimpin yang sedang berkembang dalam teknologi AI berwujud, hari ini mengumumkan pengangkatan Brian Davis sebagai Kepala Manufaktur Global....
March 31, 2026 13:53 ET | Source: Ypifany LLC

Your Business Systems Are Making Decisions Without You

See what's running in your business without you so you're the first to know when something shifts.
March 31, 2026 13:32 ET | Source: Keyword Cupid

Keyword Cupid Upgrades Its Semantic Keyword Clustering Tool With Live SERP Analysis and Finer Keyword Clusters

New York, NY , March 31, 2026 (GLOBE NEWSWIRE) -- Keyword Cupid, the SERP-based semantic keyword clustering tool that trains unsupervised machine learning models on live Google search results,...
March 31, 2026 13:11 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Vital Farms, Inc. Investors

LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vital Farms, Inc., (“Vital Farms” or the "Company") (NASDAQ: VITL) investors of a class action on behalf of investors...
March 31, 2026 11:45 ET | Source: Lacroix Group

LACROIX : EBITDA margin at 7.6%, in line with the target. Net income impacted by significant non-cash depreciations, strongly positive Free Cash Flow (+€36.6m) and sharp reduction in net debt.

31/03/2026 EBITDA margin at 7.6%, in line with the targetNet income impacted by significant non-cash depreciations,strongly positive Free Cash Flow (+€36.6m) and sharp reduction in net debt Moderate...
March 31, 2026 08:45 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
March 31, 2026 08:30 ET | Source: Volatus Aerospace Inc.

Volatus Aerospace Reports Fiscal Year 2025 Financial Results

Volatus Aerospace Reports Fiscal Year 2025 Financial Results
March 31, 2026 08:30 ET | Source: Vantive

Vantive Presents New Data at WCN on How Coordinated Care Ecosystems Can Expand Home-Based Peritoneal Dialysis Access and Improve Patient Outcomes

Nephroprotection and early intervention support more planned dialysis starts, improved patient outcomes and increased use of home therapies, according to new studies. Real-world studies also evaluate...
March 31, 2026 08:30 ET | Source: Tarsus Pharmaceuticals, Inc

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

– A pioneering investigational oral prophylactic approach designed to kill Lyme-infected ticks before disease transmission – IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Tarsus...
March 31, 2026 08:30 ET | Source: BIO-key International, Inc.

BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

HOLMDEL, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies,...